-
CLK2-BRCA1 Signaling in Platinum-Resistant Ovarian Cancer
2026-08-24
The reference study identifies Cdc2-like kinase 2 (CLK2) as a regulator of platinum resistance in ovarian cancer and links its activity to phosphorylation of BRCA1 at Ser1423. Its integrated tissue, cellular, mechanistic, and xenograft evidence positions CLK2 as a candidate target for restoring platinum sensitivity, while also defining important questions for DNA damage response research.
-
Tigecycline for Carbapenem-Resistant Pathogen Research
2026-08-24
Tigecycline provides a practical glycylcycline antibiotic comparator for multidrug-resistant pathogen assays, including plasmid-aware studies of carbapenem-resistant Enterobacter cloacae. This guide connects ribosomal inhibition, broth microdilution, plasmid transmission workflows, and troubleshooting for more interpretable antimicrobial data.
-
SP2509 Workflow for LSD1-Driven AML Research
2026-08-23
SP2509 is a selective Lysine-specific demethylase 1 antagonist for connecting LSD1 inhibition with H3K4me3 remodeling, apoptosis induction in AML cells, and differentiation-associated phenotypes. This workflow combines practical formulation guidance, mechanistic chromatin assays, AML functional readouts, and carefully bounded combination-testing strategies.
-
Ibuprofen Toxicology and Biodegradation Insights
2026-08-22
The 2023 review by Jan-Roblero and Cruz-Maya reframes ibuprofen as both a widely used COX inhibitor and a persistent emerging contaminant. It integrates evidence on environmental entry, aquatic toxicity, and bacterial biodegradation to identify gaps in monitoring and removal strategies.
-
Luteolin-SME Overcomes P-Glycoprotein Efflux
2026-08-22
The reference study developed a luteolin-loaded self-microemulsifying drug delivery system that combines improved solubilization with TPGS-mediated P-glycoprotein inhibition. In Caco-2 and pharmacokinetic models, the formulation enhanced endocytic uptake, intestinal absorption, and oral exposure while showing low cytotoxicity and hemolytic activity.
-
Polyethylenimine Linear: PEI MW 40,000 Workflows
2026-08-21
Build a scalable DNA-delivery workflow around Polyethylenimine Linear, PEI MW 40,000, from 96-well screening to transient protein expression. Practical optimization steps, cell-line guidance, and lessons from a kidney-targeted mRNA nanoparticle study help separate reproducible transfection from formulation assumptions.
-
Sphingosine-1-phosphate: Mechanism & Workflow
2026-08-20
Sphingosine-1-phosphate (S1P) is an endogenous bioactive lipid that links G-protein-coupled receptor signaling with cell proliferation and survival signaling, vascular maturation, and context-dependent apoptosis. Product specifications and recent neuronal data support using S1P as a controlled research tool rather than treating one receptor response as universal.
-
AC008406.3, Cuproptosis, and Docetaxel Response
2026-08-20
A 2026 study identifies the long non-coding RNA AC008406.3 as a suppressor of cuproptosis and a determinant of docetaxel sensitivity in breast cancer cells. Its integrated transcriptomic and experimental design connects AC008406.3 perturbation with copper accumulation, loss of lipoylated and Fe–S cluster proteins, and enhanced docetaxel activity, while also highlighting important limits of in vitro mechanistic evidence.
-
Letrozole Workflows for Aromatase Research
2026-08-19
Build reproducible estrogen-suppression assays with Letrozole, from concentration-response studies to ERα and FSH readouts. This workflow also shows how to distinguish upstream aromatase inhibition from direct estrogen-receptor modulation in breast cancer and neuroendocrine models.
-
Triiodothyronine in Adipose Thermogenesis Research
2026-08-19
Triiodothyronine (T3) gives researchers a defined thyroid-receptor perturbation for testing thermogenic and metabolic programs in adipocytes. Combined with the SETD7–Adcy7–Sirt1–CREB1 framework, it supports more discriminating cellular metabolism assays than endpoint browning measurements alone.
-
Ionomycin Free Acid: Linking Calcium and FAK
2026-08-18
Ionomycin free acid is a calcium ionophore for controlled intracellular calcium increase. This article presents a rigorous assay framework for testing how calcium-dependent proteolysis may intersect with FAISL–FAK signaling in triple-negative breast cancer.
-
DFO (9H-1,8-Diazafluoren-9-one) Guide
2026-08-18
This scenario-based guide explains how DFO (9H-1,8-Diazafluoren-9-one), SKU C6997, supports reproducible latent fingerprint detection on porous substrates while preventing confusion with deferoxamine mesylate used in biomedical studies. It covers identity, solvent compatibility, storage, controls, interpretation, and practical product-selection criteria.
-
Losmapimod Workflows for p38 MAPK Research
2026-08-17
Losmapimod, also known as GW856553X, supports controlled p38α/β MAPK inhibition across inflammation, endothelial, hypertension, and COPD-oriented studies. This workflow-centered guide combines dose-response design with phosphatase-aware assays, helping researchers separate direct kinase blockade from changes in p38 dephosphorylation.
-
Tariquidar for P-gp Chemoresistance Assays
2026-08-17
Tariquidar (XR9576) provides a practical way to separate P-glycoprotein-driven drug efflux from broader stress responses in cancer models. This guide connects transporter inhibition with viscosity-sensitive tumor mechanics, offering assay workflows, controls, and troubleshooting strategies for reproducible drug resistance research.
-
Biotin-16-UTP for RNA Labeling Workflows
2026-08-16
Biotin-16-UTP provides a biotin-labeled uridine triphosphate for incorporating an affinity handle into RNA during in vitro transcription, supporting RNA detection, capture, and interaction assays. It is intended for research workflows and should be validated for each polymerase, template, labeling density, and downstream binding format rather than used as a diagnostic or medical reagent.